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Abstract:  The  effect  of  fumonisin  B1  which  is  an  inhibitor  of  ceramide  synthesis  on  saccharide 
elongation of dodecyl ￿-lactoside (Lac-C12), which is the analogue of lactosyl ceramide (LacCer), in 
mouse melanoma B16 cells and African green-monkey kidney (Vero) cells was examined. By adding 
fumonisin B1 in the culture medium used for glycosylation of Lac-C12, mouse melanoma B16 cells 
synthesized GM3-type analogue twice much as the absence of fumonisin B1, while the amount of 
endogenous GM3 remarkably decreased. The addition of fumonisin B1 to the culture medium of Vero 
cells  also  elicited  50%  augmentation  in  the  amount  of  glycosylated  Lac-C12.  For  the  enhanced 
production of oligosaccharide using cell function, fumonisin B1 acts effectively on cells which produce 
abundant endogenous glycolipid. The addition of fumonisin B1 resulted in an increase in production of 
glycosylated Lac-C12 with decreasing natural ceramide synthesis. 
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INTRODUCTION 
 
  The  research  on  oligosaccharides  had  developed 
slowly  owing  to  their  complicated  structures  and  the 
difficulty in predicting their functions. In recent years, 
research on oligosaccharide has been developed and its 
application    to    industrial  materials  has  been 
attempted
[1-5]. The functional roles of oligosaccharides 
on the cell surface have been extensively investigated. 
It has become clear that oligosaccharides are essential 
in  many  biological  processes  such  as  cell-cell 
interaction,  proliferation,  differentiation,  cell-substrate 
interaction, carcinogenesis, bacteria or virus infection, 
immune response and inflammation
[6]. 
  Commonly,  oligosaccharides  are  obtained  from 
natural  organic  resources  such  as  calf  brain,  human 
cataractous  lenses  and  whole  plant,  etc
[7-9].  However, 
the  organic  resources  for  oligosaccharides  production 
have  limited  supply.  To  fill  the  demand  for 
oligosaccharides,  chemical
[10,11]  and  enzymatic 
synthetic  methods
[12-15]  have  been  extensively 
developed.  In  the  early  1990’s  the  novel  saccharide 
primer method for obtaining oligosaccharides utilizing 
cell function was developed involving a combination of 
chemical  synthetic  method  and  enzymatic  synthetic 
method.  The  most  important  advantage  of  the 
saccharide  primer  method
[16-18]  is  that  various 
oligosaccharides can be obtained without complicated 
processes  such  as  preparation  of  glycosyltransferase 
and multi-step chemical reactions. The principle of the 
saccharide  primer  method  is  as  follows.  The  culture 
medium is supplemented with saccharide primer such 
as  dodecyl  ￿-lactoside  (Lac-C12)  and  used  for 
incubation of cells. Consequently, the primer is taken 
into  the  cell  and  glycosylated  by  cellular 
glycosyltransferases and the glycosylated products are 
secreted into the medium. 
  Except  for  galactosylceramide,  all  kinds  of 
glycosphingolipids  are  synthesized  through 
lactosylceramide  in  mammals.  Synthesis  of 
lactosylceramide  has  been  described  to  occur  on  the 
cytosolic  face  of  the  Golgi.  Lactosylceramide  is 
generated  by  galactosylation  of  glucosylceramide 
which, in turn, is synthesized from ceramide and UDP-
Glucose  on  the  cytosolic  surface  on  the  Golgi 
apparatus
[19]. It is generally accepted that the saccharide 
primer is glycosylated by the same enzyme as in the 
synthesis of natural glycosphingolipids
[20]. 
  Fumonisin B1, an inhibitor of ceramide synthesis, 
has  been  used  to  inhibit  N-acylation  of 
sphinganine
[21,25].  It  is  also  known  that  fumonisins 
block  ceramide  biosynthesis  by  inhibiting  the Am. J. Biochem. & Biotech., 4(3): 288-294, 2008 
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conversion  of  sphinganine  to  dihydroceramides
[21]. 
Therefore,  the  effect  of  sphingolipid  synthesis 
inhibition  by  fumonisin  B1  on  the  glycosylation  of 
saccharide  primer  in  cells  was  tested.  The  effects  of 
fumonisin  B1  on  glycosylation  of  saccharide  primer 
(Lac-C12) in mouse melanoma B16 cells and African 
green-monkey kidney (Vero) cells were investigated. 
 
MATERIALS AND METHODS 
 
Materials:  Mouse  melanoma  B16  cells  and  African 
green-monkey kidney (Vero) cells were obtained from 
Riken Cell Bank (Tsukuba, Japan). High performance 
thin-layer  chromatography  (HPTLC)  plate  were  from 
Merck (Darmstadt, Germany). D-MEM and Ham’s F12 
(1:1)  (DMEM/F12),  antibioyic-antimycotic  (100×), 
Insulin-Transferrin-Selenium-X Supplement (100×) and 
trypsin/EDTA  (10×)  were  purchased  from  Invitrogen 
(Tokyo,  Japan).  Fetal  bovine  serum  (FBS)  was 
purchased  from  SAFC  Biosciences  (Lyon,  France). 
Sep-Pak  C18  columns  were  from  Waters  (Milford, 
USA). All organic solvents used for extraction of lipids 
and fumonisin B1 were purchased from Nacalai Tesque 
(Kyoto, Japan). 
 
Preparation of saccharide primer: Saccharide primer, 
n-dodecyl  ￿-lactoside  (Lac-C12),  was  prepared  as 
described  previously
[18,26].  A  mixture  of  n-dodecanol 
(2.39  g,  12.8  mmol)  and  lactose  octaacetate  (2.08  g, 
2.98 mmol) in dichloroethane (100 mL) and molecular 
sieves  4A  were  stirred  at  50°C  for  1.5  h.  Then, 
BF3·Et2O  (2.25  mL,  17.9  mmol)  was  added  and  the 
mixture was stirred at 50°C. After 3 h, the mixture was 
diluted  with  chloroform  at  room  temperature  and  the 
molecular  sieves  were  filtered  off.  The  obtained 
chloroform solution was neutralized with aq. NaHCO3, 
washed  with  H2O,  dried  with  anhydrous  Na2SO4  and 
concentrated.  Purification  was  performed  by  column 
chromatography  (silica  gel  60,  70-230  mesh,  Merck, 
Darmstadt, Germany; hexane/AcOEt 2:1, v/v). 
 
Cell culture: Mouse melanoma B16 cells and African 
green-monkey  kidney  (Vero)  cells  were  cultured  in 
DMEM/F12  supplemented  with  10%  FBS  and  1% 
antibiotic-antimycotic and detached through application 
of  0.25%  trypsin/EDTA,  passaged  every  3-4  d  and 
maintained  in  humidified  atmosphere  of  5%  CO2  at 
37°C. 
 
Oligosaccharides synthesis by cells: 2×10
6 B16 cells 
or Vero cells were seeded into 100-mm culture dishes 
containing 7  mL of  medium and incubated  for 48 h. 
Then, the cells were washed with TI-DF (D-MEM/F12 
containing  1%  Insulin-Transferrin-Selenium-X 
Supplement  and  1%  antibiotic-antimycotic)  and 
incubated  with  50  ￿M  of  n-dodecyl  ￿-lactoside  (the 
primer  was  dissolve  in  DMSO  at  an  initial 
concentration of 50 mM) at 37°C  for 48 h. Prior to the 
incubation  of  cells  with  primer,  it  was  essential  to 
remove FBS from the growth medium by washing with 
TI-DF,  since  serum  has  previously  been  observed  to 
interfere with ganglioside accumulation by the cells
[27]. 
After incubation, culture media were collected and cells 
were  washed  with  PBS  (-).  Collected  glycolipid 
analogues  from  the  culture  media  and  PBS  (-)  were 
purified  using  a  Sep-Pak  C18  column.  After  elution 
from  the  column,  the  solution  was  evaporated  and 
dissolved in 50 mL of chloroform/methanol (1:2, v/v) 
for analysis by HPTLC. 
 
Extraction of intracellular lipids: After  washing  the 
dishes used for oligosaccharide synthesis with PBS (-), 
cells were detached from the culture dishes with 0.25% 
EDTA  in  PBS  (-)  and  harvested  by  centrifugation  at 
1,000 rpm for 10 min. The cell pellet was suspended in 
1  mL  of  chloroform/methanol  (1:2,  v/v).  After 
sonication for 30 min and centrifugation at 15,000 rpm 
for 30 min, the extracts were transferred to a new tube. 
The remaining lipids from the cell pellet were extracted 
again  with  1  mL  of  chloroform/2-propanol/water 
(7:11:2,  v/v).  The  first  and  the  second  extracts  were 
pooled.  After  evaporation,  the  resulting  pellet  was 
dissolved in 50 ￿L of chloroform/methanol (1:2, v/v) 
and analyzed by HPTLC. 
 
Effect  of  fumonisin  B1  on  cellular  glycosylation: 
When seeding cells into culture dishes and incubating 
with 50 ￿M of n-dodecyl ￿-lactoside, culture medium 
was  supplemented  with  fumonisin  B1  at  a  final 
concentration of 0.1, 1, 5, 25 or 50 ￿M. Then, the cells 
were treated according to the same method as described 
above. 
 
HPTLC  analysis:  Glycolipids  from  the  cell 
homogenate and culture medium fraction were analyzed 
by  HPTLC  with  chloroform/methanol/0.25%  aqueous 
KCl  (5:4:1,  v/v)  as  developing  solvent.  The  HPTLC 
plates were sprayed with resorcinol reagent and heated 
at  120°C  to  detect  the  separated  glycolipids
[28,29]. 
Densitogram was obtained from HPTLC by using Scion 
Image  Software  (Scion  Corporation, 
http://www.scioncorp.com) to quantify glycolipids. 
 
Inverted  microscopy:  Cell  images  were  obtained  by 
using  a  Zeiss  Axiovert  40  CFL  inverted  microscope 
(Carl Zeiss, Oberkochen, Germany) with a Power Shot 
A620 camera (Canon, Tokyo, Japan), driven by Axio 
Vision  4.5  digital  image  software  (Carl  Zeiss, 
Oberkochen, Germany). Am. J. Biochem. & Biotech., 4(3): 288-294, 2008 
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Fig. 1:  Effect of fumonisin B1 on proliferation of  mouse  melanoma B16 cells (a-f) and  African green-monkey 
kidney (Vero) cells  (g-l).   Culture medium supplemented with fumonisin B1 at a final concentration of 0 (a, 
g), 0.1 mM (b, h), 1 mM (c, i), 5 mM (d, j), 25 mM (e, k) and 50 mM (f, l). 
 
 
RESULTS AND DISCUSSION 
 
  After incubation of mouse melanoma B16 cells and 
African  green-monkey  kidney  (Vero)  cells  in  culture 
medium containing 0.1, 1, 5, 25 or 50 mM of fumonisin 
B1 (preculture), the cells were used for oligosaccharide 
production via glycosylation of saccharide primer. On 
inverted  microscopy  observation,  B16  cell  grew  well 
with  low  concentration  of  fumonisin  B1  (Fig.  1a-c), 
while  the  proliferation  was  inhibited  with  higher 
concentrations than 5 mM (Fig. 1d-f). Vero cells grew 
well with every concentration of fumonisin B1 (Fig. 1g-
l).  The  culture  medium  was  replaced  by  TI-DF 
containing  50  mM  of  n-dodecyl  b-lactoside  with  the 
same  concentration  of  fumonisin  B1  as  used  for 
preculture and the cells were incubated for 2 days. The 
glycosylated  products  and  endogenous  glycolipids  in 
the culture medium and in the cells were extracted and 
analyzed  by  HPTLC,  respectively.  When  mouse 
melanoma B16 cells were incubated in the presence of 
n-dodecyl  ￿-lactoside,  GM3-type  oligosaccharide 
(NeuAc-Gal-Glc-C12) was accumulated in the culture 
medium as previously reported
[17,18] (Fig. 2a). On the 
other  hand,  GM3-type,  Gb3-type  (Gal-Gal-Glc-C12) 
and  a  small  amount  of  Gb4-type  oligosaccharides 
(GalNAc-Gal-Gal-Glc-C12)  were  obtained  when 
African  green-monkey  kidney  (Vero)  cells  were 
incubated   in  the  presence of n-dodecyl ￿-lactoside 
(Fig. 2a).  
  HPTLC results obtained from the culture of mouse 
melanoma B16 cells showed that the amount of GM3-
type  oligosaccharide  accumulated  in  the  culture 
medium increased with increasing the concentration of 
fumonisin B1, while the amount of endogenous GM3 
remarkably  decreased.  Fig.  2b  shows  the  amount  of 
GM3-type oligosaccharide that is glycosylated primer 
and  endogenous  GM3.  The  amounts  of  GM3-type 
oligosaccharide obtained from the culture with 25 ￿M Am. J. Biochem. & Biotech., 4(3): 288-294, 2008 
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Fig. 2: Effect of fumonisin B1 on glycolipid production in mouse melanoma B16 cells and African green-monkey 
kidney (Vero) cells. (a) HPTLC results of glycolipids extracted from the cell and culture medium fractions. 
(b)  The  amounts  of  GM3-type  glycolipid  and  endogenous  GM3  in  culture  medium  and  cells  were 
determined after incubation. (c) The amount of glycosylated saccharide primers in medium were determined 
after incubation 
 
or without fumonisin B1 were 22.6 and 42.6 nmol/dish, 
respectively.  The  efficiency  of  glycosylation  in  cells 
incubated  with  fumonisin  B1  for  2  days  increased  to 
about  two  times  as  compared  with  the  incubation 
without fumonisin B1. It should be noted that the total 
amounts of GM3-type oligosaccharide and endogenous 
GM3 extracted from culture were little affected by the 
addition by the addition of fumonisin B1. 
  On the other hand, African green-monkey kidney 
(Vero) cells could produce neutral Gb3-type and Gb4-
type  oligosaccharide  in  addition  to  acidic  GM3-type 
oligosaccharide.  These  oligosaccharides  were 
quantified  (Fig.  2c).  The  amount  of  GM3-type 
oligosaccharide obtained by the culture with 50 ￿M or 
without  fumonisin  B1  were  8.4  and  13.0  nmol/dish, 
respectively.  The  increasing  rate  brought  by 
supplementing  fumonisin  B1  to  the  African  green-
monkey  kidney  (Vero)  cells  culture  was  only  155%, 
which  is  smaller  as  compared  with  that  from  mouse 
melanoma B16 cells culture (188%). On the other hand, 
the  amount  of  Gb3-type  oligosaccharide  obtained  by 
the culture with 50 ￿M or without fumonisin B1 were 
9.87 and 17.2 nmol/dish, respectively. The amount of 
Gb4-type oligosaccharide obtained by the culture with 
50  ￿M  or  without  fumonisin  B1  were  1.46  and  2.95 
nmol/dish, respectively. 
  When fumonisin B1 was not supplemented to the 
culture  medium  during  preculture  but  only  during 
incubation  for  glycosylation  reaction,  the  amount  of 
oligosaccharide  produced  by  glycosylation  of  the 
saccharide  primer  only  slightly  increased  (data  not 
shown). Consequently, fumonisin B1 should be added 
during preculture of cells. 
  These  results  allowed  us  to  conclude  that 
fumonisin  B1  stimulated  oligosaccharide  production 
from  saccharide  primer  that  mimics  lactosylceramide 
(LacCer), but inhibited the production of endogenous 
glycolipids.  The  n-dodecyl  ￿-lactoside  can  be 
incorporated by cells in culture and can be utilized for 
glycolipid  synthesis.  Most  of  glycosphingolipids  in 
mammals are synthesized through LacCer intermediate. 
The  production  of  glycosylated  primers  owing  to  the 
inhibition of ceramide synthesis indicated that relatively 
large  amount  of  n-dodecyl  ￿-lactoside  was 
preferentially  glycosylated  by  cellular 
glycosyltransferases   over   small    amount  of  LacCer  Am. J. Biochem. & Biotech., 4(3): 288-294, 2008 
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Fig. 3: Inhibition of ceramide synthesis by fumonisin B1 
controled the competitive reaction with sialyl 
transferase and enhanced the productivity from 
exogenous artificial substrate 
 
(Fig.  3).  If  LacCer  is  abundant  in  cells,  the 
glycosylation  of  oligosaccharide  primer  may  be 
interrupted  due  to  the  competition  of  n-dodecyl  ￿-
lactoside with LacCer. It was reported that fumonisin 
B1  inhibited  de  novo  sphingolipid  biosynthesis  by 
neuronal cells
[23]. On the other hand, glycosylation of 
saccharide primer was promoted by fumonisin B1. The 
mouse melanoma B16 cells, which synthesize abundant 
endogenous  glycolipids,  were  induced  to  produce 
pseudo-glycolipids from saccharide primer by ceramide 
synthesis  inhibition  rather  than  the  African  green-
monkey  kidney  (Vero)  cells,  which  prepare  a  small 
amount of endogenous glycolipids. The oligosaccharide 
primer  was  utilized  as  a  favorable  substrate  for 
glycosylation,  which  was  catalyzed  by  the  cellular 
enzyme,  i.e.  glycosyltransferase,  at  low  concentration 
of  ceramide,  which  is  the  natural  substrate  for 
glycolipids synthesis (Fig. 4). Generally, the amount of 
oligosaccharide  products  obtained  by  the  saccharide 
primer method is limited because the concentration of 
the saccharide primers in the culture medium is low due 
to  its  toxicity  and  the  efficiency  of  glycosylation  is 
relatively low. 
  In general condition of B16 cell culture, a certain 
amount of GM3 expressed and the activity of the GM3 
synthase (sialyl transferase) is controlled. On the other 
hand,  the  presence  of  synthetic  substrate  (dodecyl 
lactoside)  caused  competitive  inhibition  of  the 
glycosylation of endogenous lactosyl ceramide. Most of 
the  sialylated  synthetic  substrate  was  released  to  the 
culture  medium,  while  the  endogenous  GM3  mostly 
remained in the cell. Consequently, it was considered 
that GM3  synthase   was   activated  by  the addition of  
 
 
Fig.  4:  Pathway  of  glycolipids  and  biosynthetic 
conversion  of  n-dodecyl  ￿-lactoside  to 
pseudo-glycolipids by the cells. Inhibition of 
ceramide  synthesis  by  incubation  with 
fumonisin  B1  promotes  pseudo-glycolipids 
production in the cells 
 
synthetic substrate in order to hold the certain amount 
of GM3. Moreover, the inhibition of ceramide synthesis 
by  fumonisin  B1  caused  the  significant  decrease  in 
amount of endogenous GM3 and it might result in the 
considerable activation of GM3 synthase. Therefore, in 
the  presence  of  fumonisin  B1,  the  synthetic  substrate 
was glycosylated by the considerably activated enzyme 
in  the  cell  and  the  sialylated  product  was  efficiently 
prepared. 
  In  Vero  cell  culture,  two  kinds  of  glycosyl 
transferases  predominantly  act  on  lactosyl  ceramide. 
Those are sialyl transferase and galactosyl transferase. 
Similarly to B16 cell, in the case of Vero cell also we 
may expect both enzymes to be considerably activated 
by the addition of dodecyl lactoside and fumonisin B1. 
Both  activated  sialyl  transferase  and  galactosyl 
transferase scramble for dodecyl lactoside which is the 
common  substrate.  With  increasing  the  amount  of 
fumonisin  B1,  the  amount  of  galactosylated  products 
(Gb3-type and Gb4-type) more increased than that of 
sialylated product (GM3-type) (Fig. 2c), indicating that 
the galactosyl transferase can preferentially act on the 
dodecyl  lactoside  compared  with  sialyl  transferase  in 
Vero cell. 
  As described above, the amount of oligosaccharide 
products  obtained  by  the  saccharide  primer  method 
could be increased by shingolipid synthesis inhibition. 
This strategy is expected to augment oligosaccharides 
production using saccharide primers. 
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